Company Profiles
-
MYOtherapeutics
Myotherapeutics is an early-stage biotherapeutics company focused on improving skeletal muscle function and improving mobility and quality of life in muscle-based diseases. The company has both a therapeutics division and a diagnostics division. Myotherapeutics is looking for investors to help accelerate the progress of its clinical development program.
Category:Diagnostics
Established:
-
Prolias Technologies
Prolias Technologies is an emerging molecular diagnostics company focusing on predictive and prognostic genetic cytology.
[ Visit Website ]
Category:Diagnostics
Established:
-
Pataigin, LLC.
Pataigin has developed a test that inexpensively identifies infections in less than an hour using bacterial lipid biomarkers.
[ Visit Website ]
Category:Diagnostics
Established:
-
Alba Therapeutics Corporation
Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland.
[ Visit Website ]
Category:Therapeutics
Established:
-
GlycoMantra, Inc.
Startup biotechnology firm leading the translational glycobiology research and interested in the development of carbohydrate-based therapeutics of cancer and infectious disease.
[ Visit Website ]
Category:Therapeutics
Established:
-
Gliknik Inc.
Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with cancer and immune disorders.
[ Visit Website ]
Category:Therapeutics
Established:
-
Glycocept, Inc.
Glycocept, Inc. is a UMB start-up company that has developed a novel technology, HyGly™, for modifying the binding of whole molecule antibodies to the inhibitory Fc receptor, FcgR2b.
Category:Therapeutics
-
Inhalex Therapeutics, LLC
Inhalex Therapeutics, LLC is a University of Maryland start-up that is based on a university developed technology for preventive and therapeutic strategies to address Allergy, Asthma and other Respiratory illnesses. The technology exploits proprietary immunotherapeutic compositions and the natural allergen-triggered immune response to alleviate respiratory illness associated symptoms including inflammation. The advantages of this technology over currently available strategies and therapies include, biocompatible method of intervention, and reduced dependence of anti-inflammatory drugs. Inhalex’s immediate goals are towards developing anti-allergy, asthma vaccines and eventually therapeutics.
Category:Therapeutics
Established:
-
OxyVita Inc.
Oxyvita Inc. is a biotech company specializing in developing oxygen therapeutics and biomedical products utilizing proprietary Zero-Link™ hemoglobin polymerization process.
[ Visit Website ]
Category:Therapeutics
Established:
-
Educational and Scientific, LLC
A commercial venture to conduct further research and development of medicinal plant isolates for the development of new pharmaceutical and “nutraceutical” products.
Category:Therapeutics